kt 5823 has been researched along with acetic acid in 1 studies
| Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (acetic acid) | Trials (acetic acid) | Recent Studies (post-2010) (acetic acid) |
|---|---|---|---|---|---|
| 317 | 0 | 59 | 11,160 | 293 | 4,594 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrosio, SR; Arakawa, NS; Casagrande, R; Cunha, FQ; Cunha, TM; Ferreira, SH; Mizokami, SS; Verri, WA; Zarpelon, AC | 1 |
1 other study(ies) available for kt 5823 and acetic acid
| Article | Year |
|---|---|
Kaurenoic acid from Sphagneticola trilobata Inhibits Inflammatory Pain: effect on cytokine production and activation of the NO-cyclic GMP-protein kinase G-ATP-sensitive potassium channel signaling pathway.
Topics: Acetic Acid; Administration, Oral; Animals; Asteraceae; Carbazoles; Cyclic GMP-Dependent Protein Kinases; Cytokines; Diterpenes; Dose-Response Relationship, Drug; Formaldehyde; Freund's Adjuvant; Glyburide; Inflammation; Injections, Intraperitoneal; Interleukin-8; KATP Channels; Mice; Molecular Structure; NG-Nitroarginine Methyl Ester; Pain; Tumor Necrosis Factor-alpha | 2012 |